Charalambous, Salome

High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

Boeree, M. J., Heinrich, N., Aarnoutse, R., Diacon, A. H., Dawson, R., Rehal, S., Kibiki, G. S., Churchyard, G., Sanne, I., Ntinginya, N. E., et al. (2017) · The Lancet Infectious Diseases

Tuberculosis Research and EpidemiologyInfectious Diseases and Tuberculosis

Cited by 379

Depression and alcohol use disorder at antiretroviral therapy initiation led to disengagement from care in South Africa

Cichowitz, C., Maraba, N., Hamilton, R., Charalambous, S., & Hoffmann, C. J. (2017) · PLOS ONE

HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual Risk

Cited by 38

Effectiveness of digital adherence technologies in improving tuberculosis treatment outcomes in four countries: a pragmatic cluster randomised trial protocol

Jerene, D., Levy, J., van Kalmthout, K., Rest, J. V., McQuaid, C. F., Quaife, M., Charalambous, S., Gamazina, K., Garfin, A. M. C., Mleoh, L., et al. (2023) · BMJ Open

Tuberculosis Research and EpidemiologyMobile Health and mHealth Applications

Cited by 27